Erasmus MC

Futó vizsgálatok

• Még nem toboroz

  A Phase 2 Study to Evaluate the Efficacy and Safety of Ampligen® Compared to Control Group / No Treatment Following FOLFIRINOX in Subjects with Locally Advanced Pancreatic Adenocarcinoma

  NCT05494697· 2. fázis· Forrás

• Még nem toboroz

  An open-label phase 1 dose-escalation study to evaluate safety, tolerability, pharmacokinetics, and exploratory assessments of PACAB-002 in patients with ovarian cancer with peritoneal spread

  2026-527184-15-00· 1. fázis· Forrás

• Még nem toboroz

  Long-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis

  NCT07441408· 3. fázis· Forrás

• Még nem toboroz

  A Study to Evaluate the Safety and Efficacy of AC01 Compared to Placebo in Participants With Chronic Heart Failure

  NCT07584967· 2. fázis· Forrás

• Még nem toboroz

  A study to investigate safety and efficacy of efimosfermin compared with placebo in adult participants with compensated cirrhosis (stage F4 fibrosis) due to MASH (NEBULA-2)

  2026-525757-37-00· 3. fázis· Forrás

• Még nem toboroz

  A pivotal clinical study to investigate the safety and efficacy of efimosfermin compared with placebo in adult participants with compensated cirrhosis due to Metabolic dysfunction-associated steatohepatitis (MASH)

  2026-525755-82-00· 3. fázis· Forrás

• Még nem toboroz

  To Evaluate the Long-term Safety and Tolerability of Acoramidis in Participants With Newly Diagnosed ATTR-CM (ACT-EARLY OLE)

  NCT07116473· 3. fázis· Forrás

• Még nem toboroz

  Phase II Study of Upfront SRT Plus Ivonescimab/Chemotherapy vs Ivonescimab/Chemotherapy in NSCLC Brain Mets

  NCT07234877· 2. fázis· Forrás

• Még nem toboroz

  Hepatic arterial infusion versus intravenous oxaliplatin in a safety, feasibility, and pharmacokinetic study of liver-dominant malignancies – ARTEMIS OXYS-I trial

  2026-527509-39-01· 1/2. fázis· Forrás

• Még nem toboroz

  A Phase I Study using Oncolytic AdenoVirus Immunotherapy with Repeat Administrations in Recurrent GliOblastoma (VIRAGO)

  2025-524555-31-00· 1. fázis· Forrás

• Még nem toboroz

  Tapering optimisation with placebo-based mechanisms in rheumatoid arthritis: the TOP-RA trial

  2025-524593-42-00· 4. fázis· Forrás

• Még nem toboroz

  LEAF‑HCM: What can we learn from the early use of aficamten in people who have no symptoms but do have a thickened heart muscle with blood flow obstruction?

  2025-523090-42-00· 2. fázis· Forrás

• Toboroz

  A Study of CHM-029 in Participants With NPM1 Mutated, KMT2A or NUP98 Rearranged AML

  NCT07751991· 1. fázis· Forrás

• Toboroz

  ROSY-F: Roll-over Study for Participants Who Have Completed a Previous Clinical Study with Benralizumab (Fasenra) and Benefit from Continued Treatment

  2025-523307-29-00· 3. fázis· Forrás

• Toboroz

  Phase 3 Trial of Tarlatamab (SC vs IV) In Extensive-Stage Small Cell Lung Cancer After Platinum based First-line Chemotherapy (DeLLphi-315)

  2026-525489-23-00· 3. fázis· Forrás

• Toboroz

  A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia

  NCT07623200· 3. fázis· Forrás

• Még nem toboroz

  Pompe disease; new Outcomes measures, Treatment Effect and Novel Targeted Investigations for Advancing Long-term follow-up (POTENTIAL).

  2024-520365-31-01· 4. fázis· Forrás

• Még nem toboroz

  Rollover Study for Participants Who Have Completed a Previous Clinical Study with Anifrolumab (Saphnelo) and Clinically Benefited from Continued Treatment.

  2026-526419-13-00· 3. fázis· Forrás

• Toboroz

  A Study to Investigate Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Anifrolumab in Pediatric Participants 5 to < 18 Years of Age With Systemic Lupus Erythematosus

  NCT07630714· 2. fázis· Forrás

• Toboroz

  A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF

  NCT07761117· 3. fázis· Forrás

• Toboroz

  The BALANCE Study: BlAck and Mixed Men's Lived Experience With Prostate cANCEr-Diversity in Prostate Cancer PROMS Study

  NCT07529418· Forrás

• Toboroz

  Study of Lenacapavir, Teropavimab, and Zinlirvimab in Virologically Suppressed Adults With HIV-1 on Stable Oral Treatment Regimens

  2025-524336-19-00· 3. fázis· Forrás

• Toboroz

  Tarlatamab for SCLC Brain Metastases

  NCT07402343· 2. fázis· Forrás

• Toboroz

  A Trial to Study if REGN5837 in Combination with Odronextamab is Safe for Adult Participants with Aggressive B-cell Non-Hodgkin Lymphomas

  NCT05685173· 1. fázis· Forrás

• Még nem toboroz

  Giving Upfront Anti-p40 to Reduce toxicity from Dual Immune Checkpoint Inhibition in Mesothelioma

  2026-526036-38-00· 2. fázis· Forrás

• Toboroz

  A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis

  NCT07497087· 3. fázis· Forrás

• Toboroz

  Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden

  NCT07621809· 3. fázis· Forrás

• Toboroz

  Discontinuation of Disease-modifying Anti-rheumatic Drugs (DMARDs) in Rheumatoid Arthritis Patients Also Using TNF Inhibitors

  NCT07802678· 4. fázis· Forrás

• Toboroz

  DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy

  NCT07544654· 3. fázis· Forrás

• Toboroz

  A Study to Find an Efficacious and Safe Dose of CHF10067 (Zampilimab) in Participants With Idiopathic Pulmonary Fibrosis

  NCT07516951· 2. fázis· Forrás

• Toboroz

  Guideline Implementation and Quality of Care Evaluation in Patients With Heart Failure and Reduced Ejection Fraction (HFrEF)

  NCT07702760· Forrás

• Még nem toboroz

  A more sustainable perioperative treatment regimen for gastroesophageal cancer —replacing 5-FU with capecitabine within the FLOT regimen

  2026-526209-13-00· 1. fázis· Forrás

• Még nem toboroz

  Does a higher radiation dose prolong survival of patients with limited-stage small cell lung cancer receiving immunotherapy after chemotherapy and radiation therapy (DAHRTS trial)?

  2026-525513-31-00· 3. fázis· Forrás

• Fut, nem toboroz

  Intraperitoneal irinotecan with concomitant FOLFOX and bevacizumab for patients with unresectable colorectal peritoneal metastases – a phase II study

  NCT06003998· 2. fázis· Forrás

• Toboroz

  PROTECx - Pembrolizumab Registry for Outcomes and Treatment Evaluation in Cervical Cancer

  2025-522883-34-00· 4. fázis· Forrás

• Toboroz

  European Study of the BrioVAD Heart Pump for Advanced Heart Failure

  NCT07252531· Forrás

• Még nem toboroz

  PREOPANC-6 study: dendritic cell immunotherapy after FOLFIRINOX chemotherapy in patients with resectable pancreatic cancer

  2025-523134-28-00· 2/3. fázis· Forrás

• Toboroz

  Boosting Osimertinib Blood Brain Barrier Penetration

  NCT07485452· 2. fázis· Forrás

• Még nem toboroz

  A PRECISION MEDICINE RANDOMIZED TRIAL FOR PATIENTS WITH RELAPSED OR REFRACTORY T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA BASED ON A FUNCTIONAL APPROACH. ALL-TARGET TRIAL

  2024-516570-30-00· 2. fázis· Forrás

• Toboroz

  Crohn’s Head-to-Head Assessing Risankizumab Versus Guselkumab for One Year

  2025-521590-13-00· 3. fázis· Forrás

• Toboroz

  A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis

  NCT07577856· 3. fázis· Forrás

• Toboroz

  A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease

  NCT07577843· 3. fázis· Forrás

• Toboroz

  A Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia (MK-1045-005)

  NCT07570173· 2/3. fázis· Forrás

• Toboroz

  A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of DNL952 in Adult Participants With Late-Onset Pompe Disease

  NCT07354724· 1. fázis· Forrás

• Toboroz

  Pembrolizumab Registry for Outcomes and Treatment Evaluation in Cervical Cancer

  NCT07645625· 4. fázis· Forrás

• Toboroz

  IMMUNOPEC: Combination of neo-adjuvant Checkpoint Inhibition and Dendritic Cell Therapy (MesoPher) with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in patients with Peritoneal Mesothelioma

  2024-519626-21-00· 2. fázis· Forrás

• Toboroz

  Assessing the Impact of Intensification of Lipid Lowering Therapy With Guidelines-based Evinacumab Administration on Coronary Plaque Volumes Measured by Coronary Computed Tomography Angiography (CCTA) in Patients With Homozygous Familial Hypercholesterolemia (HoFH)

  NCT07447648· Forrás

• Toboroz

  A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)

  NCT07419295· 3. fázis· Forrás

• Toboroz

  A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)

  NCT07409181· 2. fázis· Forrás

• Toboroz

  Neoadjuvant gemcitabine and cisplatin in combination with perioperative pembrolizumab versus upfront surgery for patients with primary resectable and borderline resectable perihilar and distal cholangiocarcinoma (NEODISCO): A Multicentre Phase 2B/3 Randomised Controlled Trial

  2024-516898-72-00· 2/3. fázis· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Tüdőrák22 toboroz
• Vastagbélrák19 toboroz
• Máj- és epeúti rák16 toboroz
• Gyomor- és nyelőcsőrák15 toboroz
• Hólyagrák14 toboroz
• Gyermekkori daganatok13 toboroz
• Melanóma13 toboroz
• Hasnyálmirigyrák12 toboroz
• Mielóma multiplex12 toboroz
• Glioblasztóma11 toboroz
• Prosztatarák10 toboroz
• Szívelégtelenség10 toboroz
• Petefészekrák9 toboroz
• Crohn-betegség8 toboroz
• Pompe-betegség8 toboroz
• Fej-nyaki daganatok7 toboroz
• Zsírmáj (MASLD/MASH)7 toboroz
• Méhtestrák6 toboroz
• Akut mieloid leukémia (AML)5 toboroz
• Amiloidózis5 toboroz
• Idiopátiás tüdőfibrózis5 toboroz
• Méhnyakrák5 toboroz
• Rheumatoid arthritis5 toboroz
• HIV-fertőzés4 toboroz
• Magas vérnyomás4 toboroz
• Mezotelióma4 toboroz
• Neuroendokrin daganatok4 toboroz
• Vesedaganat4 toboroz
• Akut limfoid leukémia (ALL)3 toboroz
• Arthritis psoriatica3 toboroz
• Cisztás fibrózis3 toboroz
• Hipertrófiás kardiomiopátia3 toboroz
• Hodgkin-limfóma3 toboroz
• Koszorúér-betegség3 toboroz
• Krónikus vesebetegség3 toboroz
• Lupus (SLE)3 toboroz
• Áttétes emlőrák2 toboroz
• Diffúz nagy B-sejtes limfóma (DLBCL)2 toboroz
• Elhízás2 toboroz
• Familiáris hiperkoleszterinémia2 toboroz
• Follikuláris limfóma2 toboroz
• Köpenysejtes limfóma2 toboroz
• Krónikus gyulladásos demielinizációs polineuropátia (CIDP)2 toboroz
• Krónikus limfoid leukémia (CLL)2 toboroz
• Migrén2 toboroz
• Pajzsmirigyrák2 toboroz
• Policisztás vesebetegség2 toboroz
• Sclerosis multiplex (SM)2 toboroz
• Sjögren-szindróma2 toboroz
• Stroke (szélütés)2 toboroz
• Szisztémás szklerózis (szkleroderma)2 toboroz
• Tripla negatív emlőrák2 toboroz
• 2-es típusú cukorbetegség1 toboroz
• ANCA-asszociált vasculitis1 toboroz
• Asztma1 toboroz
• Atópiás dermatitisz (ekcéma)1 toboroz
• Autizmus spektrumzavar1 toboroz
• Colitis ulcerosa1 toboroz
• Csontritkulás1 toboroz
• Epilepszia1 toboroz
• Frontotemporális demencia1 toboroz
• Hemofília1 toboroz
• Hepatitis B (krónikus)1 toboroz
• Mieloproliferatív neopláziák1 toboroz
• Neuromyelitis optica (NMOSD)1 toboroz
• Pikkelysömör1 toboroz
• Primer biliáris cholangitis (PBC)1 toboroz
• Pulmonális artériás hipertónia1 toboroz
• Sarlósejtes vérszegénység1 toboroz
• Spondylitis ankylopoetica (Bechterew-kór)1 toboroz
• Szarkóma1 toboroz

Kutatók

Ide még nem kötődik kutató.

Lezárt vizsgálatok

• Lezárult

  A trial to learn how safe AZD9750 is and how well it works in people with metastatic prostate cancer when given with or without other anticancer drugs

  2024-516976-14-00· 1/2. fázis· Forrás

• Fut, nem toboroz

  Phase 2a Study of VX-407 in Participants With ADPKD Who Have a Subset of PKD1 Gene Variants (AGLOW)

  NCT07161037· 2. fázis· Forrás

• Lezárult

  lmlifidase treatment tor acute inflammation in AQP4-lgG associated neuromyelitis optica spectrum disorder

  2024-517176-38-00· 2. fázis· Forrás

• Toboroz

  Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis

  NCT06699849· 2. fázis· Forrás

• Fut, nem toboroz

  A Phase 3 Study of Zodasiran in Adolescent and Adult Subjects With Homozygous Familial Hypercholesterolemia (YOSEMITE)

  NCT07037771· 3. fázis· Forrás

• Lezárult

  A Study of the Efficacy and Safety of Efgartigimod in Patients with Primary Sjögren's Syndrome (pSjD) (UNITY)

  NCT06684847· 3. fázis· Forrás

• Toboroz

  DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

  NCT06989112· 3. fázis· Forrás

• Lezárult

  The rimegePant in RElation to obeSiTy in mIGrainE study

  2024-513359-34-00· 4. fázis· Forrás

• Fut, nem toboroz

  A Phase 2 Study of Anvumetostat in Participants With MTAP-deleted Advanced NSCLC (MTAPESTRY 201)

  NCT06593522· 2. fázis· Forrás

• Lezárult

  A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027)

  NCT06637423· 1/2. fázis· Forrás

• Lezárult

  Study in Asymptomatic GRN-FTD Patients to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VES001

  NCT06705192· 1. fázis· Forrás

• Fut, nem toboroz

  A Study Assessing Adverse Events and Disease Activity of Intravenously (IV) Infused Telisotuzumab Adizutecan in Adult Participants With c-Met Protein Above Cutoff Level Above Refractory Metastatic Colorectal Cancer

  NCT06614192· 2. fázis· Forrás

• Lezárult

  THE (COST)EFFECTIVENESS OF NEOADJUVANT FOLFIRINOX VERSUS NEOADJUVANT GEMCITABINE BASED CHEMORADIOTHERAPY AND ADJUVANT GEMCITABINE FOR (BORDERLINE) RESECTABLE PANCREATIC CANCER (PREOPANC-2 STUDY)

  2024-516260-29-00· 3. fázis· Forrás

• Lezárult

  Comparing the effectiveness of our tailor-made management approach with routine care from a clinical, patient's as well as an economic point of view. Tailoring of treatment is done by taking the presence of autoantibodies and the quick response to glucocorticoids and JAK inhibitors into account.

  2024-511530-12-01· 4. fázis· Forrás

• Lezárult

  Phase 2 study to evaluate the efficacy and safety of GSK3915393 in participants with Idiopathic Pulmonary Fibrosis (IPF)

  NCT06317285· 2. fázis· Forrás

• Lezárult

  A study to test whether BI 1839100 improves cough in people with idiopathic pulmonary fibrosis or progressive pulmonary fibrosis

  2023-510249-79-00· 2. fázis· Forrás

• Toboroz

  Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)

  NCT06274801· 3. fázis· Forrás

• Toboroz

  Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer

  NCT06467357· 3. fázis· Forrás

• Lezárult

  Optimizing reversal of HIV latency with combination therapy (pyrimethamine, lenalidomide, panobinostat)

  NCT06240520· 2. fázis· Forrás

• Lezárult

  A study evaluating the safety and efficacy of GLPG5101 (19CP02) in subjects with non-Hodgkin lymphoma

  NCT06561425· 1/2. fázis· Forrás

• Fut, nem toboroz

  A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With NRAS-mutant Melanoma (SEACRAFT-2)

  NCT06346067· 3. fázis· Forrás

• Lezárult

  A Study to Test Whether Survodutide Helps People Living With Obesity or Overweight and With a Confirmed or Presumed Liver Disease Called Non-alcoholic Steatohepatitis (NASH) to Reduce Liver Fat and to Lose Weight (SYNCHRONIZE-MASLD)

  NCT06309992· 3. fázis· Forrás

• Lezárult

  A proof of concept and dose-finding study of XXB750 in patients with heart failure

  2023-504678-39-00· 2. fázis· Forrás

• Lezárult

  Effect of EMD Protocol for Urge on Dermatology-specific Quality of Life

  NCT06427122· Forrás

• Lezárult

  A Study of AMG 355 Alone and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors

  NCT06131398· 1. fázis· Forrás

• Fut, nem toboroz

  A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Participants Aged 12 Years and Older With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK Inhibitor

  NCT06241118· 3. fázis· Forrás

• Toboroz

  A trial to learn how effective and safe odronextamab is compared to standard of care for adult participants with previously treated aggressive B-cell Non-Hodgkin Lymphoma.

  NCT06230224· 3. fázis· Forrás

• Visszavonták

  INTRUSION: Unraveling the INTRatUmoral PK/PD relatION for SAR408701

  NCT05703555· 2. fázis· Forrás

• Lezárult

  Repurposed Drugs in Research for Cancer Clinical Trials- Pitavastatin

  NCT05977738· Korai 1. fázis· Forrás

• Meghívásos bevonás

  Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS)

  NCT06191315· 3. fázis· Forrás

• Lezárult

  Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA)

  NCT05934526· 3. fázis· Forrás

• Fut, nem toboroz

  A study to investigate the efficacy and safety of tezepelumab compared with placebo in children 5 to < 12 years old with severe asthma

  2022-502984-39-00· 3. fázis· Forrás

• Lezárult

  STRIDER: A phase II Study evaluaTing intRacranial effIcacy of JDQ443 in patiEnts with KRAS G12C+ NSCLC and bRain metastases

  2023-505721-13-00· 2. fázis· Forrás

• Lezárult

  A Study of Mirikizumab (LY3074828) in Pediatric Participants With Moderately to Severely or Active Ulcerative Colitis

  NCT05784246· 3. fázis· Forrás

• Lezárult

  A phase I/II open label, multicenter study evaluating the feasibility, safety and efficacy of point-of-care manufactured antiBCMA CAR T cells (GLPG5301; BCMACP03) in subjects with relapsed/refractory Multiple Myeloma (RRMM)

  2022-500782-27-00· 1/2. fázis· Forrás

• Toboroz

  A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer

  NCT06095089· 1. fázis· Forrás

• Lezárult

  A Phase 3b, Open-label Study to Evaluate the Effectiveness and Safety of Lebrikizumab Treatment in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis

  2023-505558-16-00· 3. fázis· Forrás

• Fut, nem toboroz

  A Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM)

  NCT06081894· 3. fázis· Forrás

• Lezárult

  A 32-week Trial to Evaluate the Efficacy and Safety of Tralokinumab in Subjects With Moderate-to-severe Atopic Hand Eczema Who Are Candidates for Systemic Therapy

  NCT05958407· 3. fázis· Forrás

• Lezárult

  A Study of Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) in Adults With Heterozygous Familial Hypercholesterolemia (MK-0616-017/CORALreef HeFH)

  NCT05952869· 3. fázis· Forrás

• Lezárult

  Evaluation of Elexacaftor/Tezacaftor/Ivacaftor (ELX/TEZ/IVA) in Cystic Fibrosis (CF) Participants 12 to Less Than 24 Months of Age

  NCT05882357· 3. fázis· Forrás

• Fut, nem toboroz

  A Study of Efficacy and Safety of Pembrolizumab Plus Enfortumab Vedotin (EV) +/- Investigational Agents in First-Line Metastatic Urothelial Carcinoma (mUC) (MK-3475-04B/KEYMAKER-U04)

  NCT05845814· 1/2. fázis· Forrás

• Lezárult

  Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Metoprolol Succinate in Adults With Symptomatic oHCM

  NCT05767346· 3. fázis· Forrás

• Fut, nem toboroz

  Study Comparing Tarlatamab With Standard of Care Chemotherapy in Relapsed Small Cell Lung Cancer

  NCT05740566· 3. fázis· Forrás

• Lezárult

  A study to see how well CVGBM vaccine works at different doses and how safe it is in patients who had surgery for glioblastoma or astrocytoma

  2022-501423-25-00· 1/2. fázis· Forrás

• Lezárult

  The Effectiveness of Adding Braun Anastomosis to Standard Child Reconstruction After Pancreatoduodenectomy

  NCT05709197· Forrás

• Lezárult

  A Randomized, Double-blind, Placebo-controlled Clinical Study to Evaluate Mavacamten in Adults with Cardiomyopathy

  NCT05582395· 3. fázis· Forrás

• Lezárult

  A Phase 1 Study of the SHP2 Inhibitor BBP-398 (formerly known as IACS-15509) in combination with the KRAS-G12C Inhibitor Sotorasib in Patients with Advanced Solid Tumors and a KRAS-G12C Mutation

  NCT05480865· 1. fázis· Forrás

• Lezárult

  PriskA Pilot Study

  NCT05785507· Forrás

• Lezárult

  Safety and Tolerability of AC01 in patients with heart failure

  2022-500347-20-00· 1/2. fázis· Forrás

Vizsgálati helyszínek

• Erasmus MC0 vizsgálat
• Erasmus MC2 vizsgálat
• Erasmus MC109 vizsgálat
• Erasmus MC - Centrum1 vizsgálat
• Erasmus MC, Department of Neurosurgery1 vizsgálat
• Erasmus MC/ Erasmus Medisch Centrum0 vizsgálat
• Erasmus MC Rotterdam3 vizsgálat
• Erasmus MC (Site 0031)1 vizsgálat
• Erasmus MC (Site 0182)0 vizsgálat
• Erasmus MC (Site 0332)1 vizsgálat
• Erasmus MC (Site 0451)0 vizsgálat
• Erasmus MC (Site 0475)1 vizsgálat
• Erasmus MC (Site 1300)0 vizsgálat
• Erasmus MC (Site 1913)1 vizsgálat
• Erasmus MC (Site 5000)0 vizsgálat
• Erasmus MC (Site 5303)0 vizsgálat
• Erasmus MC - Thoraxcenter2 vizsgálat
• Erasmus MC - Universitair Medisch Centrum - Medical oncology1 vizsgálat
• Erasmus MC, University Medical Center Rotterdam2 vizsgálat
• Erasmus Medical Center Rotterdam0 vizsgálat
• Erasmus Medisch Centrum (Erasmus MC)0 vizsgálat
• Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)439 vizsgálat
• Erasmus University Medical Center27 vizsgálat
• Erasmus University Medical Center, Department of Medical Oncology1 vizsgálat
• Erasmus University Medical Center, Dr. Molewaterplein 401 vizsgálat
• Erasmus University Medical Center Rotterdam3 vizsgálat
• Erasmus University Medical Center (Site 0352)1 vizsgálat
• Erasmus University Medical Center (Site 1354)1 vizsgálat
• Erasmus University Medical Centre5 vizsgálat
• Erasmus University Medical Centre (MC)0 vizsgálat
• Erasmus University Medical Centre Rotterdam0 vizsgálat
• Gastroenterology and Hepatology, Rotterdam Erasmus Medical Center1 vizsgálat
• Medical Microbiology & Infectious Diseases, Erasmus MC1 vizsgálat
• Rotterdam Erasmus Medical Center1 vizsgálat
• The Erasmus MC1 vizsgálat
• Thoraxcenter, Erasmus MC1 vizsgálat
• University Medical Centre Rotterdam - Erasmus University Medical Center1 vizsgálat
• Erasmus MC0 vizsgálat
• Erasmus MC0 vizsgálat
• Erasmus MC2 vizsgálat

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Szívelégtelenség372 munka · 24 vizsgálat
• Stroke (szélütés)370 munka · 6 vizsgálat
• Elhízás303 munka · 6 vizsgálat
• Prosztatarák251 munka · 25 vizsgálat
• Tüdőrák241 munka · 66 vizsgálat
• Vastagbélrák187 munka · 29 vizsgálat
• Pitvarfibrilláció165 munka · 6 vizsgálat
• 2-es típusú cukorbetegség142 munka · 1 vizsgálat
• Koszorúér-betegség136 munka · 10 vizsgálat
• Asztma133 munka · 3 vizsgálat
• Gyomor- és nyelőcsőrák128 munka · 25 vizsgálat
• Rheumatoid arthritis115 munka · 8 vizsgálat
• Hasnyálmirigyrák114 munka · 21 vizsgálat
• Krónikus vesebetegség114 munka · 9 vizsgálat
• Máj- és epeúti rák99 munka · 22 vizsgálat
• Akut mieloid leukémia (AML)81 munka · 13 vizsgálat
• Petefészekrák65 munka · 17 vizsgálat
• Glioblasztóma65 munka · 17 vizsgálat
• Skizofrénia58 munka · 0 vizsgálat
• Migrén58 munka · 3 vizsgálat
• Melanóma52 munka · 22 vizsgálat
• Krónikus obstruktív tüdőbetegség (COPD)50 munka · 1 vizsgálat
• Autizmus spektrumzavar48 munka · 1 vizsgálat
• Depresszió47 munka · 1 vizsgálat
• Méhnyakrák38 munka · 11 vizsgálat
• Hipertrófiás kardiomiopátia36 munka · 8 vizsgálat
• Hólyagrák33 munka · 23 vizsgálat
• Frontotemporális demencia33 munka · 5 vizsgálat
• Crohn-betegség33 munka · 11 vizsgálat
• Idiopátiás tüdőfibrózis30 munka · 16 vizsgálat